NTCOC
UTHR icon

Northern Trust Company of Connecticut’s United Therapeutics UTHR Stock Holding History

Northern Trust Company of Connecticut’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$19.4M Buy
171,883
+3,338
+2% +$301K 0.12% 223
2013
Q3 		$13.3M Sell
168,545
-172
-0.1% -$12.6K 0.09% 340
2013
Q2 		$11.1M Buy
+168,717
New +$10.9M 0.08% 383

Other funds holding UTHR

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's UTHR Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its United Therapeutics (UTHR) stake by 2% in Q4 2013, buying an estimated $301K and bringing the position to 171,883 shares worth $19.4M. The position accounts for 0.12% of the portfolio, ranked #223.

Northern Trust Company of Connecticut first reported a position in UTHR in Q2 2013 and has held it in 3 quarters since. 321 funds tracked by Wall St. Rank hold UTHR as of Q4 2013.

  • Northern Trust Company of Connecticut held 171,883 shares of United Therapeutics worth $19.4M as of Q4 2013.
  • Northern Trust Company of Connecticut bought 3,338 United Therapeutics shares in Q4 2013, an estimated $301K.
  • United Therapeutics made up 0.12% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #223 holding.
  • Northern Trust Company of Connecticut first reported a position in United Therapeutics in Q2 2013 and has held it in 3 quarters since.
  • 321 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.